Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene

MeSH terms

• Adult
• Aminoglycosides / administration & dosage
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Arsenic Trioxide
• Arsenicals / administration & dosage
• Benzoates / administration & dosage
• Benzoates / therapeutic use*
• Bone Marrow / pathology
• Bone Neoplasms / diagnostic imaging
• Bone Neoplasms / drug therapy
• Bone Neoplasms / secondary
• Combined Modality Therapy
• Doxorubicin / administration & dosage
• Drug Resistance, Neoplasm
• Gemtuzumab
• Hematopoietic Stem Cell Transplantation
• Humans
• Idarubicin / administration & dosage
• Leukemia, Promyelocytic, Acute / drug therapy*
• Leukemia, Promyelocytic, Acute / surgery
• Leukemic Infiltration / drug therapy
• Leukemic Infiltration / pathology
• Male
• Mercaptopurine / administration & dosage
• Methotrexate / administration & dosage
• Oxides / administration & dosage
• Radionuclide Imaging
• Remission Induction
• Salvage Therapy*
• Sarcoma, Myeloid / diagnostic imaging
• Sarcoma, Myeloid / drug therapy
• Soft Tissue Neoplasms / diagnostic imaging
• Soft Tissue Neoplasms / drug therapy
• Soft Tissue Neoplasms / secondary
• Tetrahydronaphthalenes / administration & dosage
• Tetrahydronaphthalenes / therapeutic use*
• Tretinoin / administration & dosage